BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 990 filers reported holding BAXTER INTL INC in Q4 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $208,574 | +89416.7% | 4,578 | 0.0% | 0.01% | -16.7% |
| Q4 2022 | $233 | -99.9% | 4,578 | 0.0% | 0.01% | -14.3% |
| Q3 2022 | $247,000 | -20.6% | 4,578 | -5.5% | 0.01% | -22.2% |
| Q2 2022 | $311,000 | -19.4% | 4,847 | -2.7% | 0.01% | 0.0% |
| Q1 2022 | $386,000 | -16.5% | 4,981 | -7.4% | 0.01% | -10.0% |
| Q4 2021 | $462,000 | +7.9% | 5,381 | +1.2% | 0.01% | 0.0% |
| Q3 2021 | $428,000 | 0.0% | 5,318 | 0.0% | 0.01% | -9.1% |
| Q2 2021 | $428,000 | -4.7% | 5,318 | 0.0% | 0.01% | -8.3% |
| Q1 2021 | $449,000 | +5.2% | 5,318 | 0.0% | 0.01% | 0.0% |
| Q4 2020 | $427,000 | +13.0% | 5,318 | +13.1% | 0.01% | 0.0% |
| Q3 2020 | $378,000 | -4.1% | 4,703 | +2.7% | 0.01% | -20.0% |
| Q2 2020 | $394,000 | +5.9% | 4,578 | 0.0% | 0.02% | -11.8% |
| Q1 2020 | $372,000 | -2.9% | 4,578 | 0.0% | 0.02% | +21.4% |
| Q4 2019 | $383,000 | -4.2% | 4,578 | 0.0% | 0.01% | -6.7% |
| Q3 2019 | $400,000 | +6.7% | 4,578 | 0.0% | 0.02% | 0.0% |
| Q2 2019 | $375,000 | +0.8% | 4,578 | 0.0% | 0.02% | -6.2% |
| Q1 2019 | $372,000 | +23.6% | 4,578 | 0.0% | 0.02% | +6.7% |
| Q4 2018 | $301,000 | -14.7% | 4,578 | 0.0% | 0.02% | -6.2% |
| Q3 2018 | $353,000 | -21.6% | 4,578 | -25.0% | 0.02% | -20.0% |
| Q2 2018 | $450,000 | +0.2% | 6,100 | -11.6% | 0.02% | -9.1% |
| Q1 2018 | $449,000 | 0.0% | 6,900 | -0.8% | 0.02% | -8.3% |
| Q4 2017 | $449,000 | +3.7% | 6,953 | +0.8% | 0.02% | -4.0% |
| Q3 2017 | $433,000 | +3.6% | 6,900 | 0.0% | 0.02% | 0.0% |
| Q2 2017 | $418,000 | +16.8% | 6,900 | 0.0% | 0.02% | +13.6% |
| Q1 2017 | $358,000 | +16.2% | 6,900 | -0.6% | 0.02% | +4.8% |
| Q4 2016 | $308,000 | -28.7% | 6,941 | -23.5% | 0.02% | -30.0% |
| Q3 2016 | $432,000 | +9.9% | 9,069 | +4.2% | 0.03% | +7.1% |
| Q2 2016 | $393,000 | -52.2% | 8,700 | -56.5% | 0.03% | -52.5% |
| Q1 2016 | $822,000 | -39.6% | 20,015 | -43.8% | 0.06% | -41.6% |
| Q4 2015 | $1,360,000 | -18.4% | 35,637 | -29.7% | 0.10% | -22.9% |
| Q3 2015 | $1,666,000 | -9.6% | 50,702 | +88.4% | 0.13% | -8.4% |
| Q2 2015 | $1,843,000 | 0.0% | 26,909 | 0.0% | 0.14% | 0.0% |
| Q1 2015 | $1,843,000 | +266.4% | 26,909 | +292.3% | 0.14% | +217.8% |
| Q4 2014 | $503,000 | +1.0% | 6,859 | -1.2% | 0.04% | -2.2% |
| Q3 2014 | $498,000 | +16.6% | 6,940 | +17.6% | 0.05% | +17.9% |
| Q2 2014 | $427,000 | +2.6% | 5,900 | +4.4% | 0.04% | -4.9% |
| Q1 2014 | $416,000 | +5.9% | 5,650 | 0.0% | 0.04% | 0.0% |
| Q4 2013 | $393,000 | +5.9% | 5,650 | 0.0% | 0.04% | -4.7% |
| Q3 2013 | $371,000 | +1.9% | 5,650 | +7.6% | 0.04% | -2.3% |
| Q2 2013 | $364,000 | – | 5,250 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GENERATION INVESTMENT MANAGEMENT LLP | 21,171,371 | $1,817,350,000 | 7.47% |
| Soditic Asset Management LLP | 147,620 | $12,672,000 | 6.53% |
| NUANCE INVESTMENTS, LLC | 4,084,218 | $350,589,000 | 6.17% |
| PRAGMA GESTAO DE PATRIMONIO LTD | 145,000 | $12,447 | 5.96% |
| Veritas Asset Management LLP | 12,222,261 | $1,049,159,000 | 5.89% |
| Pavadi Capital LLC | 72,782 | $6,248,000 | 4.74% |
| Sonen Capital LLC | 48,907 | $4,198,000 | 4.06% |
| Glenview Capital Management | 2,182,422 | $187,339,000 | 3.99% |
| Dash Acquisitions Inc. | 103,963 | $8,924,000 | 3.87% |
| Avidity Partners Management LP | 1,765,000 | $151,508,000 | 3.21% |